|
NDC74-4029-03
|
6505-01-023-1034
|
Usp Sterile Water For Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC74-4029-03
|
6505-01-023-1034
|
Usp Sterile Water For Injection |
Abbott Laboratories
|
|
Quote
|
|
NDC74-4029-03
|
6505-01-023-1034
|
Usp Sterile Water For Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC74-4029-03
|
6505-01-023-1034
|
Usp Sterile Water For Injection |
Abbott Laboratories
|
|
Quote
|
|
NDC74-4029-03
|
6505-01-023-1034
|
Usp Sterile Water For Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC74-4029-03
|
6505-01-023-1034
|
Usp Sterile Water For Injection |
Abbott Laboratories
|
|
Quote
|
|
NDC91-5617-31
|
6505-01-023-1035
|
Usp Nitroglycerin Ointment |
Schwarz Pharma Inc.
|
|
Quote
|
|
NDC91-5617-31
|
6505-01-023-1035
|
Usp Nitroglycerin Ointment |
Schwarz Pharma Inc.
|
|
Quote
|
|
NDC91-5617-31
|
6505-01-023-1035
|
Usp Nitroglycerin Ointment |
Schwarz Pharma Inc.
|
|
Quote
|
|
NITROL
|
6505-01-023-1036
|
Usp Nitroglycerin Ointment |
Schwarz Pharma Inc.
|
|
Quote
|
|
NDC00091-5617-02
|
6505-01-023-1036
|
Usp Nitroglycerin Ointment |
Schwarz Pharma Inc.
|
|
Quote
|
|
NITROL
|
6505-01-023-1036
|
Usp Nitroglycerin Ointment |
Schwarz Pharma Inc.
|
|
Quote
|
|
NDC00091-5617-02
|
6505-01-023-1036
|
Usp Nitroglycerin Ointment |
Schwarz Pharma Inc.
|
|
Quote
|
|
NITROL
|
6505-01-023-1036
|
Usp Nitroglycerin Ointment |
Schwarz Pharma Inc.
|
|
Quote
|
|
NDC00091-5617-02
|
6505-01-023-1036
|
Usp Nitroglycerin Ointment |
Schwarz Pharma Inc.
|
|
Quote
|
|
NDC00182-0698-01
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00002-0803-02
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Eli Lilly and Company
|
|
Quote
|
|
02660
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC02-0803-02
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Eli Lilly and Company
|
|
Quote
|
|
NDC00182-0698-01
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Goldline Laboratories Inc.
|
|
Quote
|
|
02660
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00002-0803-02
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Eli Lilly and Company
|
|
Quote
|
|
NDC02-0803-02
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Eli Lilly and Company
|
|
Quote
|
|
02660
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-0698-01
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00002-0803-02
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Eli Lilly and Company
|
|
Quote
|
|
NDC02-0803-02
|
6505-01-023-1037
|
Propoxyphene Hydrochloride Capsu |
Eli Lilly and Company
|
|
Quote
|
|
NDC00005-3592-34
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
American Cyanamid Co
|
|
Quote
|
|
NDC00143-1765-10
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
15043
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-0791-10
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00904-2342-80
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Major Crown Inc
|
|
Quote
|
|
1394060
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Major Crown Inc
|
|
Quote
|
|
1394060
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Major Crown Inc
|
|
Quote
|
|
NDC00904-2342-80
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Major Crown Inc
|
|
Quote
|
|
NDC00143-1765-10
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
15043
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-0791-10
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00005-3592-34
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
American Cyanamid Co
|
|
Quote
|
|
NDC00904-2342-80
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Major Crown Inc
|
|
Quote
|
|
1394060
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Major Crown Inc
|
|
Quote
|
|
NDC00143-1765-10
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
15043
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-0791-10
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00005-3592-34
|
6505-01-023-1040
|
Isosorbide Dinitrate Sublingual |
American Cyanamid Co
|
|
Quote
|
|
P-200
|
6505-01-023-1048
|
Papaverine Hydrochloride Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
NDC00524-0034-01
|
6505-01-023-1048
|
Papaverine Hydrochloride Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
P-200
|
6505-01-023-1048
|
Papaverine Hydrochloride Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
NDC00524-0034-01
|
6505-01-023-1048
|
Papaverine Hydrochloride Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
P-200
|
6505-01-023-1048
|
Papaverine Hydrochloride Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
NDC00524-0034-01
|
6505-01-023-1048
|
Papaverine Hydrochloride Tablets |
Boots Pharmaceuticals Inc
|
|
Quote
|
|
INDERAL TABLETS
|
6505-01-023-1051
|
Propranolol Hydrochloride Tablet |
Pfizer Inc.
|
|
Quote
|
|
INDERAL
|
6505-01-023-1051
|
Propranolol Hydrochloride Tablet |
Pfizer Inc.
|
|
Quote
|
|
NDC00904-0411-61
|
6505-01-023-1051
|
Propranolol Hydrochloride Tablet |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC57480-0355-01
|
6505-01-023-1051
|
Propranolol Hydrochloride Tablet |
Medirex Inc
|
|
Quote
|
|
NDC00364-0756-90
|
6505-01-023-1051
|
Propranolol Hydrochloride Tablet |
Schein Pharmaceutical Inc
|
|
Quote
|
|
NDC00182-1812-89
|
6505-01-023-1051
|
Propranolol Hydrochloride Tablet |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC51079-0277-20
|
6505-01-023-1051
|
Propranolol Hydrochloride Tablet |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00046-0421-99
|
6505-01-023-1051
|
Propranolol Hydrochloride Tablet |
Pfizer Inc.
|
|
Quote
|
|
NDC00781-1490-01
|
6505-01-023-1055
|
Amitriptyline Hydrochloride Tabl |
Sandoz Inc.
|
|
Quote
|
|
NDC00310-0043-10
|
6505-01-023-1055
|
Amitriptyline Hydrochloride Tabl |
Zeneca Inc
|
|
Quote
|
|
NDC00364-0577-01
|
6505-01-023-1055
|
Amitriptyline Hydrochloride Tabl |
Schein Pharmaceutical Inc
|
|
Quote
|
|
NDC00038-0043-10
|
6505-01-023-1055
|
Amitriptyline Hydrochloride Tabl |
Zeneca Inc
|
|
Quote
|
|
NDC00781-1490-01
|
6505-01-023-1055
|
Amitriptyline Hydrochloride Tabl |
Geneva Pharmaceuticals Inc
|
|
Quote
|
|
NDC04-0107-14
|
6505-01-023-1056
|
Amitriptyline Hydrochloride Tabl |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC04-0107-14
|
6505-01-023-1056
|
Amitriptyline Hydrochloride Tabl |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC04-0107-14
|
6505-01-023-1056
|
Amitriptyline Hydrochloride Tabl |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00781-1489-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-2675-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
01426
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00310-0042-10
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Astrazeneca Lp
|
|
Quote
|
|
NDC00310-0042-10
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Zeneca Inc
|
|
Quote
|
|
NDC00364-0576-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Schein Pharmaceutical Inc
|
|
Quote
|
|
NDC38245-0209-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Copley Pharmaceutical Inc
|
|
Quote
|
|
NDC00182-1021-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00038-0042-10
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Zeneca Inc
|
|
Quote
|
|
NDC00536-3074-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Rugby Group Inc
|
|
Quote
|
|
NDC00603-2215-21
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC00378-2675-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Mylan Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00781-1489-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-2675-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00378-2675-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Mylan Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00603-2215-21
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC00781-1489-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-2675-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00378-2675-01
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Mylan Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00603-2215-21
|
6505-01-023-1057
|
Amitriptyline Hydrochloride Tabl |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC00074-7125-60
|
6505-01-023-1064
|
Multivitamin And Mineral Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
CONTROLLED-RELEASED TABS
|
6505-01-023-1064
|
Multivitamin And Mineral Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
04-0839
|
6505-01-023-1064
|
Multivitamin And Mineral Tablets |
Defense Logistics Agency
|
|
Quote
|
|
IBERET-FOLIC-500 TABLETS
|
6505-01-023-1064
|
Multivitamin And Mineral Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
7125-60
|
6505-01-023-1064
|
Multivitamin And Mineral Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
52152-0048-14
|
6505-01-023-1064
|
Multivitamin And Mineral Tablets |
Amide Pharmaceutical Inc
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
168-0011-15
|
6505-01-023-1635
|
Usp Bacitracin Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
A-A-30025
|
6505-01-023-3319
|
Hemorrhoidal Suppositories |
Federal Commercial Item Description
|
|
Quote
|
|
ANUSOL
|
6505-01-023-3319
|
Hemorrhoidal Suppositories |
Parke-davis
|
|
Quote
|
|
NDC00713-0121-12
|
6505-01-023-3319
|
Hemorrhoidal Suppositories |
G & W Laboratories, Inc.
|
|
Quote
|
|
NDC00071-1088-07
|
6505-01-023-3319
|
Hemorrhoidal Suppositories |
Parke-davis
|
|
Quote
|
|
NDC00182-0742-11
|
6505-01-023-3319
|
Hemorrhoidal Suppositories |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC45802-0434-01
|
6505-01-023-5011
|
Usp Clotrimazole Cream |
Perrigo Company
|
|
Quote
|
|
NDC45802-0434-01
|
6505-01-023-5011
|
Usp Clotrimazole Cream |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC51672-1275-01
|
6505-01-023-5011
|
Usp Clotrimazole Cream |
Taro Pharmaceuticals Usa Inc
|
|
Quote
|
|
NDC00182-5095-33
|
6505-01-023-5011
|
Usp Clotrimazole Cream |
Ivax Corp
|
|
Quote
|
|
ISOPTO TEARS
|
6505-01-023-5074
|
Hydroxypropyl Methylcellulose Op |
Alcon Canada Inc
|
|
Quote
|
|
408
|
6505-01-023-5074
|
Hydroxypropyl Methylcellulose Op |
Alcon Canada Inc
|
|
Quote
|
|
62-1332-51
|
6505-01-023-5240
|
Norethindrone And Mestranol Tabl |
Ortho Pharmaceutical Corp
|
|
Quote
|
|
R1001
|
6505-01-023-5241
|
Usp Sterile Water For Irrigation |
B Braun Medical Inc
|
|
Quote
|
|
R1201
|
6505-01-023-5242
|
Usp Sodium Chloride Irrigation |
B Braun Medical Inc
|
|
Quote
|
|
25-901-437
|
6505-01-023-5243
|
Norethindrone Acetate And Ethiny |
Parke-davis
|
|
Quote
|
|
1002-01
|
6505-01-023-5244
|
Isoetharine Hydrochloride And Ph |
Gutz Logistics Inc
|
|
Quote
|
|
NDC00467-0187-25
|
6505-01-023-6749
|
Modifi Sodium Chloride Injection |
Invenex Laboratories
|
|
Quote
|
|
187100
|
6505-01-023-6749
|
Modifi Sodium Chloride Injection |
Invenex Laboratories
|
|
Quote
|
|
187100
|
6505-01-023-6749
|
Modifi Sodium Chloride Injection |
Invenex Laboratories
|
|
Quote
|
|
NDC00467-0187-25
|
6505-01-023-6749
|
Modifi Sodium Chloride Injection |
Invenex Laboratories
|
|
Quote
|
|
BLEPH-10 LIQUIFILM
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
AK-SULF
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
SULAMYD
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
NDC17478-0221-12
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
70650
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-0671-64
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC24208-0670-04
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC00904-2728-35
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC11980-0011-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
NDC61314-0701-01
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC00998-0522-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO CETAMIDE
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00085-0946-06
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
NDC00998-0522-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
BLEPH-10 LIQUIFILM
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
AK-SULF
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
SULAMYD
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
70650
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-0671-64
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC61314-0701-01
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC11980-0011-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
NDC00904-2728-35
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC17478-0221-12
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
NDC00085-0946-06
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
ISOPTO CETAMIDE
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00998-0522-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
BLEPH-10 LIQUIFILM
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
AK-SULF
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
SULAMYD
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
70650
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-0671-64
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00904-2728-35
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC11980-0011-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Allergan Inc
|
|
Quote
|
|
NDC61314-0701-01
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC17478-0221-12
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Akorn Inc
|
|
Quote
|
|
NDC00085-0946-06
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Schering Laboratories
|
|
Quote
|
|
ISOPTO CETAMIDE
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00998-0522-15
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC24208-0670-04
|
6505-01-023-8713
|
Sulfacetamide Sodium Ophthalmic |
Valeant Pharmaceuticals
|
|
Quote
|
|
VELOSEF 500 CAPSULES
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Co
|
|
Quote
|
|
NDC00781-2534-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Sandoz Inc.
|
|
Quote
|
|
NDC00555-0551-02
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Barr Laboratories, Inc.
|
|
Quote
|
|
NDC00332-3155-09
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Biocraft Laboratories Inc
|
|
Quote
|
|
NDC00182-1254-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00182-1254-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Co
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
VELOSEF 500 CAPSULES
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00781-2534-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Sandoz Inc.
|
|
Quote
|
|
NDC00555-0551-02
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Barr Laboratories, Inc.
|
|
Quote
|
|
NDC00332-3155-09
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Biocraft Laboratories Inc
|
|
Quote
|
|
NDC00182-1254-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Bristol-myers Co
|
|
Quote
|
|
NDC00003-0114-50
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
VELOSEF 500 CAPSULES
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00781-2534-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Sandoz Inc.
|
|
Quote
|
|
NDC00182-1254-01
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00555-0551-02
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Barr Laboratories, Inc.
|
|
Quote
|
|
NDC00332-3155-09
|
6505-01-023-8714
|
Usp Cephradine Capsules |
Biocraft Laboratories Inc
|
|
Quote
|
|
TALWIN
|
6505-01-024-2626
|
Us Pentazocine Lactate Injection |
Sterling-winthrop Research Institute
|
|
Quote
|
|
NDC00074-1941-01
|
6505-01-024-2626
|
Us Pentazocine Lactate Injection |
Abbott Laboratories
|
|
Quote
|
|
BENDECTIN62476
|
6505-01-024-2653
|
Doxylamine Succinate And Pyridox |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
